Physician profile
Daniel Aloysius Hammer
NPI 1821349655
$200,650.68
in general payments reported to CMS, 2019-2025
12 companies · $58K in 2025
The $58K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,157 · 2020: $468 · 2021: $1,494 · 2022: $12K · 2023: $73K · 2024: $54K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $98K · Travel and Lodging: $30K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Honoraria: $11K · Food and Beverage: $7,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $97,857.50 |
| Travel and Lodging | $30,481.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,165.63 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,019.70 |
| Honoraria | $11,000.00 |
| Food and Beverage | $7,916.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $136,238.03 | 2019-2025 | Na, Patient-Fitted Tmj Reconstructive Prosthesis System, Vsp System, Vsp Cranial |
| Axogen | $43,185.91 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Kls-Martin L.P. | $16,563.77 | 2019-2025 | |
| Synthes Gmbh | $2,306.06 | 2024 | |
| Depuy Synthes Sales INC. | $933.34 | 2019-2025 | Trumatch |
| Medical Device Business Services, INC. | $842.35 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $169.12 | 2019 | |
| Longeviti Neuro Solutions INC | $156.31 | 2021 | |
| Avita Medical Americas, LLC | $123.81 | 2025 | Permeaderm, Recell, Cohealyx |
| Integra Lifesciences Corporation | $73.68 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| 3d Systems | $31.20 | 2025 | |
| Geistlich Pharma, North America, INC. | $27.10 | 2025 | Biomaterials |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hammer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.